Want to see GB:FDBK full AI Analyst Report?
Feedback (FDBK) Share Price & Analysis
FDBK Stock Chart & Stats
- Day’s Range
- GBX 4.85 - GBX 4.85
- 52-Week Range
- GBX 4.50 - GBX 15.00
- Previous Close
- GBX 5.15
- Volume
- N/A
- Average Volume (3M)
- 113.12K
- Market Cap
- GBP 2.26M
- Enterprise Value
- -GBP 328.77K
- Total Cash (Recent Filing)
- GBP 3.82M
- Total Debt (Recent Filing)
- GBP 0
- Price to Earnings (P/E)
- ―
- Beta
- 1.00
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
Feedback's zero-debt balance sheet meaningfully reduces refinancing and interest-rate risk. For a small digital-health software provider, no financial leverage preserves strategic flexibility and extends runway, allowing management to pursue restructuring or growth without fixed financing obligations.
High Gross Margin
An ~88% gross margin indicates strong software unit economics: cost of delivering incremental subscriptions is low. If revenue stabilizes or grows, this margin profile can drive operating leverage and faster conversion of revenue into sustainable profits over the medium term.
Recurring SaaS Revenue Model
Feedback's business relies on recurring licence/subscription and services revenue, which supports predictable cash flows and customer retention dynamics. Structural recurring revenue aids long-term planning and margins, especially if the company secures framework or public-sector contracts that lengthen contract visibility.
Bears Say
Sharp Revenue Decline
A sustained ~25-30% revenue decline materially reduces the addressable recurring base for a SaaS business. Lower recurring sales hinder absorption of fixed operating costs, slow path to profitability, and make it difficult to leverage the company's high gross margins into improved operating results without revenue stabilization.
Very Large Operating Losses
Extremely large and worsening net losses relative to tiny sales indicate operating costs far exceed the revenue base. Persistent deep losses erode shareholder capital, constrain reinvestment in product or sales, and increase reliance on external financing or dilution to sustain operations over the medium term.
Persistent Cash Burn & Equity Erosion
Consistent negative operating and free cash flow (~-2.8m latest) coupled with falling equity reduces financial resilience. Ongoing cash burn shortens runway and raises the probability of fundraising, which can constrain strategic options and slow product or sales investment needed to restore growth.
Feedback News
FDBK FAQ
What was Feedback’s price range in the past 12 months?
What is Feedback’s market cap?
When is Feedback’s upcoming earnings report date?
How were Feedback’s earnings last quarter?
Is Feedback overvalued?
Does Feedback pay dividends?
What is Feedback’s EPS estimate?
How many shares outstanding does Feedback have?
What happened to Feedback’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Feedback?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Feedback
Feedback plc is a medical technology company, headquartered in London, UK, and established in 1958, that supplies specialized software and systems to individuals and organizations working within the medical imaging sector. Their product portfolio includes TexRAD, a patented software tool designed to extract and quantify textural features within radiological images. This assists research into all types of tumors and helps uncover biomarkers in medical imagery. They also offer TexRAD Lung, a specific software tool used for the clinical analysis of lung cancer within the European Union. Additionally, the company provides the Cadran image platform, a robust picture archiving and communication system (PACS) for hospitals and research institutes, capable of handling images from various imaging modalities like CT and PET scanners. Another key offering is Bleepa, a secure platform for clinical communications that facilitates the safe sharing of high-quality medical images.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Thomas James Oakley
- Employees
- 29
- Website
- feedbackmedical.com
- Address
- 201 Temple Chambers, London, GL, EC4Y 0DT, GB
Feedback (FDBK) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |










